1. Search Result

Search Result

Targets Recommended: p38 MAPK

Results for "1375469-38-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-100886
    BAY1082439

    PI3K Apoptosis Cancer
    BAY1082439 is an orally bioavailable, selective PI3Kα/β/δ inhibitor. BAY1082439 also inhibits mutated forms of PIK3CA. BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth.